The selling by MPM entities is modest relative to market cap and involves only venture-capital 10% owners, not C-suite executives, this cluster is unlikely to signal material negative information. Monitor for any subsequent 8-K or press release that could explain the selling, but the default expectation is routine portfolio rebalancing by early-stage investors.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 1 $7.07entry
- T+1 · 3mo ago +3.25%α +2.81% · $7.30
- T+5 · 2mo ago +0.57%α +0.48% · $7.11
- T+20 · 7w ago −10.18%α −10.50% · $6.35
- T+53 · todayOpen
- T+60 · in 8d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two 10% owner entities (MPM BioVentures 2014 and 2018) sold a combined 88.5K shares for ~$619K in open-market sales over two days, while the CEO had a routine tax-withholding transaction. The selling is modest at ~0.22% of market cap, and as a cluster of sells by non-C-suite insiders, it carries limited predictive signal per academic literature.
Key Financial Metrics
Key Facts
- Two MPM BioVentures entities (10% owners) sold 44,259 shares each on 2026-08-31 at $6.99, totaling ~$618K
- CEO Doshi Dipal had a routine tax-withholding transaction of 8,724 shares on 2026-09-02 with no open-market activity
- Total open-market selling of ~$618K represents ~0.22% of TRDA's $284M market cap
- No C-suite executives engaged in open-market sales; selling is limited to venture capital 10% owners
Financial Impact
Open-market sales of ~$618K by two 10% owner entities, representing ~0.22% of market cap
Risk Factors
- Venture capital 10% owners may have additional selling pressure if they continue to reduce positions
- TRDA's small $284M market cap makes it susceptible to disproportionate price moves from any insider selling
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TRDA-1788472085124 |
Track record
21 reports on TRDA
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +58.22% at T+20 after the May 4, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 4/10 No price data
- Nov 5, 202611d ago Press Release Neutral 4/10 Entry $4.55 Now $5.00 +9.89% settles Feb 3
- Oct 14, 20264w ago 8-K Bullish 6/10 Entry $4.55 Now $5.00 +9.89% settles Jan 11
- Sep 9, 20269w ago Insider Cluster Bearish 6/10 Entry $6.42 Now $5.00 +22.12% settles Dec 4
- Sep 3, 202610w ago Insider Cluster Neutral 3/10 Entry $7.13 Now $5.00 −29.87% settles Dec 1
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Viewing Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 3/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $7.27 Now $5.00 −31.22% settles Nov 20
- Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $7.04 to $5.06 Now $5.00 −28.98% ▼ −28.13% −27.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers